MYGN
Income statement / Annual
Last year (2022), Myriad Genetics, Inc.'s total revenue was $678.40 M,
a decrease of 1.77% from the previous year.
In 2022, Myriad Genetics, Inc.'s net income was -$112.00 M.
See Myriad Genetics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
06/30/2014 |
| Operating Revenue |
$678.40 M
|
$690.60 M
|
$557.00 M
|
$851.10 M
|
$851.10 M
|
$772.60 M
|
$771.40 M
|
$753.80 M
|
$723.10 M
|
$778.22 M
|
| Cost of Revenue |
$202.00 M |
$197.60 M |
$178.20 M |
$201.00 M |
$201.00 M |
$177.20 M |
$171.20 M |
$157.30 M |
$147.40 M |
$109.20 M |
| Gross Profit |
$476.40 M |
$493.00 M |
$378.80 M |
$650.10 M |
$650.10 M |
$595.40 M |
$600.20 M |
$596.50 M |
$575.70 M |
$669.02 M |
| Gross Profit Ratio |
0.7 |
0.71 |
0.68 |
0.76 |
0.76 |
0.77 |
0.78 |
0.79 |
0.8 |
0.86 |
| Research and Development
Expenses |
$85.40 M
|
$81.90 M
|
$80.90 M
|
$85.90 M
|
$85.90 M
|
$70.80 M
|
$74.40 M
|
$70.60 M
|
$75.50 M
|
$67.48 M
|
| General & Administrative
Expenses |
$514.70 M
|
$599.80 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$514.70 M
|
$599.80 M
|
$500.70 M
|
$555.50 M
|
$555.50 M
|
$467.10 M
|
$476.40 M
|
$359.10 M
|
$366.00 M
|
$327.10 M
|
| Other Expenses |
$600,000.00 |
$139.30 M |
$0.00 |
$1.20 M |
$1.20 M |
-$400,000.00 |
-$2.50 M |
$1.20 M |
$300,000.00 |
-$1.97 M |
| Operating Expenses |
$600.10 M |
$681.70 M |
$653.30 M |
$641.40 M |
$641.40 M |
$537.90 M |
$550.80 M |
$429.70 M |
$441.50 M |
$394.57 M |
| Cost And Expenses |
$802.10 M |
$879.30 M |
$831.50 M |
$842.40 M |
$842.40 M |
$715.10 M |
$722.00 M |
$587.00 M |
$588.90 M |
$503.77 M |
| Interest Income |
$2.60 M |
$700,000.00 |
$9.20 M |
$3.20 M |
$3.20 M |
$1.80 M |
$1.20 M |
$900,000.00 |
$400,000.00 |
$5.40 M |
| Interest Expense |
$3.20 M |
$6.60 M |
$0.00 |
$12.00 M |
$12.00 M |
$3.20 M |
$6.00 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$55.90 M
|
$62.80 M
|
$71.40 M
|
$73.00 M
|
$73.00 M
|
$54.40 M
|
$48.30 M
|
$26.70 M
|
$25.00 M
|
$13.82 M
|
| EBITDA |
-$67.80 M
|
$14.10 M
|
-$123.40 M
|
$86.10 M
|
$86.10 M
|
$113.30 M
|
$96.40 M
|
$193.50 M
|
$159.20 M
|
$274.44 M
|
| EBITDA Ratio |
-0.1 |
0.02 |
-0.22 |
0.1 |
0.1 |
0.15 |
0.12 |
0.26 |
0.22 |
0.35 |
| Operating Income Ratio
|
-0.18
|
-0.07
|
-0.35
|
0.01
|
0.01
|
0.15
|
0.06
|
0.22
|
0.19
|
0.35
|
| Total Other
Income/Expenses Net |
-$16.90 M
|
-$8.40 M
|
-$88.90 M
|
$100,000.00
|
$100,000.00
|
$60.80 M
|
-$1.70 M
|
$1.20 M
|
$300,000.00
|
-$1.97 M
|
| Income Before Tax |
-$140.60 M |
-$57.10 M |
-$283.70 M |
$200,000.00 |
$7.70 M |
$116.90 M |
$42.90 M |
$168.90 M |
$134.90 M |
$277.87 M |
| Income Before Tax Ratio
|
-0.21
|
-0.08
|
-0.51
|
0
|
0.01
|
0.15
|
0.06
|
0.22
|
0.19
|
0.36
|
| Income Tax Expense |
-$28.60 M |
-$29.90 M |
$59.90 M |
-$4.40 M |
-$4.40 M |
-$13.90 M |
$21.30 M |
$43.60 M |
$54.70 M |
$101.64 M |
| Net Income |
-$112.00 M |
-$27.20 M |
-$223.70 M |
$4.60 M |
$4.60 M |
$131.00 M |
$21.80 M |
$125.30 M |
$80.20 M |
$176.23 M |
| Net Income Ratio |
-0.17 |
-0.04 |
-0.4 |
0.01 |
0.01 |
0.17 |
0.03 |
0.17 |
0.11 |
0.23 |
| EPS |
-1.39 |
-0.35 |
-2.99 |
0.0626 |
0.06 |
1.89 |
0.32 |
1.79 |
1.12 |
2.33 |
| EPS Diluted |
-1.39 |
-0.35 |
-2.99 |
0.0605 |
0.06 |
1.82 |
0.32 |
1.71 |
1.08 |
2.25 |
| Weighted Average Shares
Out |
$80.58 M
|
$77.71 M
|
$74.70 M
|
$73.50 M
|
$73.50 M
|
$69.40 M
|
$68.30 M
|
$70.00 M
|
$71.30 M
|
$75.73 M
|
| Weighted Average Shares
Out Diluted |
$80.60 M
|
$78.00 M
|
$74.78 M
|
$76.00 M
|
$76.00 M
|
$72.00 M
|
$68.80 M
|
$73.40 M
|
$74.50 M
|
$78.18 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
